Literature DB >> 7274357

Effect of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat.

S M Wuerthele, W J Freed, L Olson, J Morihisa, L Spoor, R J Wyatt, B J Hoffer.   

Abstract

Pieces of fetal rat mesencephalon containing the substantia nigra were transplanted into the lateral ventricle of rats pretreated with 6-OHDA injections into the ipsilateral substantia nigra. Extracellular recordings from these grafts revealed spontaneously active neurons with action potential waveforms and firing rates similar to those found in substantia nigra zona compacta in situ. Furthermore, local application of dopamine agonists inhibited, while dopamine antagonists increased zona compacta activity, both in situ and of cells from nigral grafts. We conclude that substantia nigra grafts contain spontaneously active neurons similar to those of zona compacta in situ, and that some of the mechanisms regulating nigral neuronal activity in situ are also present in this preparation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7274357     DOI: 10.1007/BF00238743

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  16 in total

1.  A quantitative microiontophoretic analysis of the responses of central neurones to noradrenaline: interactions with cobalt, manganese, verapamil and dichloroisoprenaline.

Authors:  R Freedman; B J Hoffer; D J Woodward
Journal:  Br J Pharmacol       Date:  1975-08       Impact factor: 8.739

2.  Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.

Authors:  K Gale; E Costa; G Toffano; J S Hong; A Guidotti
Journal:  J Pharmacol Exp Ther       Date:  1978-07       Impact factor: 4.030

3.  Transplanted neural tissue develops connections with host rat brain.

Authors:  R D Lund; S D Hauschka
Journal:  Science       Date:  1976-08-13       Impact factor: 47.728

Review 4.  Self-inhibition by dopaminergic neurons.

Authors:  P M Groves; C J Wilson; S J Young; G V Rebec
Journal:  Science       Date:  1975-11-07       Impact factor: 47.728

5.  Electrophysiological analysis reinnervation of transplants in the anterior chamber of the eye by the autonomic ground plexus of the iris.

Authors:  D Taylor; A Seiger; R Freedman; L Olson; B Hoffer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

6.  Intracephalic implants: a technique for studying neuronal interactions.

Authors:  L F Kromer; A Bjorklund; U Stenevi
Journal:  Science       Date:  1979-06-08       Impact factor: 47.728

7.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

8.  Transplantation of embryonic neural tissue in the mammalian brain. I. Growth and differentiation of neuroblasts from various regions of the embryonic brain in the cerebellum of neonate rats.

Authors:  G D Das
Journal:  TIT J Life Sci       Date:  1974

9.  Brain tissue transplanted to the anterior chamber of the eye. 1. Fluorescence histochemistry of immature catecholamine and 5-hydroxytryptamine neurons reinnervating the rat iris.

Authors:  L Olson; A Seiger
Journal:  Z Zellforsch Mikrosk Anat       Date:  1972

10.  Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies.

Authors:  W J Freed; M J Perlow; F Karoum; A Seiger; L Olson; B J Hoffer; R J Wyatt
Journal:  Ann Neurol       Date:  1980-11       Impact factor: 10.422

View more
  10 in total

1.  Regulatory aspects of nigrostriatal dopaminergic neurons.

Authors:  P Miu; F Karoum; G Toffano; J W Commissiong
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

Review 2.  Transplantation into the human brain: present status and future possibilities.

Authors:  O Lindvall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 3.  Transplantation of embryonic dopamine neurons: what we know from rats.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

4.  The future role of neurosurgery in medicine.

Authors:  W Luyendijk
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

5.  Time-course of recovery of dopamine neuron activity during reinnervation of the denervated striatum by fetal mesencephalic grafts as assessed by in vivo voltammetry.

Authors:  C Forni; P Brundin; R E Strecker; S el Ganouni; A Björklund; A Nieoullon
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

Review 6.  Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials.

Authors:  Curt R Freed; Wenbo Zhou; Robert E Breeze
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

7.  Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.

Authors:  J W Commissiong; C Slimovitch; G Toffano
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

8.  Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry.

Authors:  D J Clarke; P Brundin; R E Strecker; O G Nilsson; A Björklund; O Lindvall
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

Review 9.  Fetal tissue transplantation for patients with Parkinson's disease: a database of published clinical results.

Authors:  E D Clarkson
Journal:  Drugs Aging       Date:  2001       Impact factor: 4.271

Review 10.  Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease.

Authors:  Nathan C Rowland; Suneil K Kalia; Lorraine V Kalia; Paul S Larson; Daniel A Lim; Krystof S Bankiewicz
Journal:  Mol Ther Methods Clin Dev       Date:  2016-01-13       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.